Genomma Lab appoints founder interim CEO. October 21 results matter for Genomma Lab stock

Published on 10/15/2026 at 11:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At Lang & Schwarz, Genomma Lab stock costs EUR 0.67 on October 15, 2026. Q2 revenue reached MXN 4.40 billion versus MXN 4.19 billion in Q1.

Leadership transition and results date

Rodrigo Herrera will become interim CEO on January 1, 2027, for a 12 to 18 month mandate.
Second-quarter revenue reached MXN 4.40 billion versus MXN 4.19 billion in the first quarter of 2026.
Genomma Lab stock trades at EUR 0.67 at 11:00 a.m. CEST at Lang & Schwarz on October 15, 2026.

Genomma Lab, MX01LA010006, Illustration mit AI erstellt.

Genomma Lab (ISIN MX01LA010006) was trading at EUR 0.67 at Lang & Schwarz on October 15, 2026 at 11:00 a.m. CEST. The company is preparing a leadership change after PR Newswire reported on September 17, 2026 that founder Rodrigo Herrera Aspra will become interim chief executive officer on January 1, 2027. The transition puts execution of a new operating model at the center of the stock story.

Results show a mixed operating picture

For the second quarter of 2026, revenue reached MXN 4.40 billion, up from MXN 4.19 billion in the first quarter, while net income was MXN 374.49 million. Investing.com also reported a second-quarter profit margin of 8.52 percent and described the quarter as a period of weaker sales but higher net income compared with the prior year.

The comparison with the first quarter is important: revenue increased by 4.93 percent, while net income declined from MXN 494.65 million to MXN 374.49 million. That split leaves the upcoming report focused on whether sales growth can translate into stronger earnings.

Three dates define the transition

On July 22, 2026, Genomma Lab listed its second-quarter earnings release among its investor events. On September 17, 2026, the company announced that Herrera would take the interim CEO role for 12 to 18 months. On October 1, 2026, it announced the date for the third-quarter report on October 21, 2026, after the Mexican Stock Exchange close, in a release carried by TradingView.

What does the operating model mean?

The leadership plan covers 18 countries and combines brand launches, digital platforms, content creators and product availability. The company said the artificial intelligence platform had already been tested with Suerox Mineral, with results due at Genomma Day in New York on December 3, 2026. The stated mandate is concrete: extend the launch model across the portfolio, embed the platform in daily operations and pursue new businesses through potential partnerships.

Results arrive before Genomma Day

The next two scheduled dates are the third-quarter earnings release on October 21, 2026, and the conference call on October 22, 2026 at 11:00 a.m. Mexico City time. The sequence gives investors two separate checkpoints for the operating model: near-term financial delivery and the longer-term strategy presentation.

Stock holds a dated euro indication

Genomma Lab stock was trading at EUR 0.67 at Lang & Schwarz on October 15, 2026 at 11:00 a.m. CEST. The Mexican listing was quoted at MXN 13.44 on October 14, 2026, while its market capitalization was MXN 13.1 billion on that date.

The further course of trading is shown by the continuously updated real-time quote of Genomma Lab stock.